期刊文献+

淫羊藿总黄酮对高脂血症大鼠主动脉血管内皮功能的影响 被引量:10

Effects of total flavonoids of epimedium on aorta vascular endothelial function in hyperlipidemic rats
下载PDF
导出
摘要 目的:探讨淫羊藿总黄酮(TFE)对喂养高脂饮食的大鼠主动脉一氧化氮(NO)及一氧化氮合酶(NOS)的影响以及抗动脉粥样硬化(AS)的可能机制。方法:将35只SD大鼠随机分为普通饮食组(n=9)和高脂饮食组(n=26)。后者喂以高脂饮食12周后,检测空腹血脂,若已出现高脂血症说明造模成功,再随机分为模型组、小剂量[100 mg/(kg.只)]TFE组及大剂量[200 mg/(kg.只)]TFE组。16周后,检测各组血脂水平,三酰甘油(TG)用TPO-PAP法检测,总胆固醇(TC)用CHOD-PAP法检测,低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)用选择性沉淀法检测。主动脉NO水平通过硝酸还原法检测、用精氨酸催化法检测主动脉总NOS(tNOS)、诱导型NOS(iNOS)及构成型NOS(cNOS)(等于tNOS与iNOS之差)的水平。结果:以高脂饮食喂养12周后,高脂饮食组TG、TC及LDL的水平明显升高(P<0.01)。给药4周后,与模型组比较,TFE组大鼠的血脂谱能明显改善,TC和TG的水平明显降低(P<0.05,P<0.01)。模型组主动脉NO和cNOS的水平显著下降(P<0.05,P<0.01),TFE组主动脉NO和cNOS的水平显著提高(P<0.05,P<0.01)。结论:TFE能改善血脂及提高主动脉NO、cNOS的水平。 AIM: To explore total flavonoids of epimedium (TFE) on nitric oxide (NO) and nitric oxide synthetase (NOS) in aorta in hyperlipidemic rats and to explore the possible mechanism of anti-atherosclerosis (AS). METHODS: According to body weight, 35 male Sprague Dawley (SD) rats were randomly divided into the full diet group ( n = 9 ) and the high-fat (HF) diet group ( n = 26) that was fed a HF diet for 12 weeks. Serum lipid levels were then measured. An ideal experimental rat model of hyperlipidemia was made when lipid level was higher in the HF diet group. According to body weight, 26 male SD rats were then randomly divided into three groups, namely, model group, low-dose [ 100 mg/( kg. rat) ] TFE group and high-dose [200 rag/( kg -rat) ] TFE group. After 16 weeks of feeding, serum lipid (TG, TC, LDL-C, HI)L-C) level was measured. Triglycerides (TG) were measured by CHOD-PAP method, total cholesterol (TC) was detected by CHOD-PAP, and low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were measured by selectivity precipitation method. NO was determined by nitric acid reductase method, and iNOS and tNOS were determined by catalytic method (cNOS activity was obtained by subtracting iNOS activity from the total NOS activity). RESULTS: After 12 weeks of feeding, compared with those in the full diet group, the levels of TG, TG, and LDL-C in HF diet group significantly increased ( P 〈 0. 01 ). After a 4-week treatment, compared with the model group, levels of TC and TG in TFE group were obviously lower ( P 〈 0. 05 or P 〈 0. 01 ). The model group showed lower NO and cNOS concentrations (P 〈 0. 05 or P 〈 0.01 ). The level of NO and cNOS of in the TFE group increased significantly (P 〈 0. 05, P 〈 0. 01 ). CONCLUSION: TFE reduces blood lipid levels and elevates NO and cNOS levels of vascular aorta in hyperlipidemic rats.
出处 《心脏杂志》 CAS 2011年第4期455-458,共4页 Chinese Heart Journal
基金 中国博士后基金项目资助(20090461491)
关键词 淫羊藿总黄酮 高脂血症 一氧化氮 一氧化氮合酶 大鼠 total flavonoids epimedium hyperlipidemia nitric oxide nitric oxide synthetase
  • 相关文献

参考文献12

  • 1Kastelein JJ, vanLeuven SI, Burgess L, et al. Effect of tarcetrapib on carotid atherosclerosis in familial hypercholesterolemia[ J]. N En- gl J Med, 2007, 356(16) :1620 - 1630.
  • 2Kagota S, Yamaguchi Y, Tanaka N, et al. Disturbances in nitric ox- ide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome [ J ]. Life Sci, 2006, 78 ( 11 ) : 1187 - 1196.
  • 3薛永亮,唐宁,华晓东,卞卡.一氧化氮与动脉粥样硬化[J].中国动脉硬化杂志,2009,17(8):698-701. 被引量:19
  • 4Xu HB, Huang ZQ. Icariin enhances endothelial nitric-oxide syn- thase expression on human endothelial cells in vitro [ J ]. Vascul Pharmacol, 2007, 47 ( 1 ) : 18 - 24.
  • 5Osto E, Matter CM, Kouroedov A, et al. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress [ J ]. Circulation, 2008, 118 ( 20 ) : 2073 - 2080.
  • 6Victor VM, Rocha M, Sola E, et al. Oxidative stress, endothelial dysfunction and atherosclerosis [ J ]. Curr Pharm Des, 2009, 15 (26) :2988 - 3002.
  • 7C R A, T M C B, C M, et al. Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic Syndrome[ J ]. Open Biochem J, 2008, 2 : 108 - 115.
  • 8Nematbakhsh M, Haghjooyjavanmard S, Mahmoodi F, et al. The prevention of endothelial dysfunction through endothelial cell apopto- sis inhibition in a hypercholestemlemic rabbit model: the effect of L-arginine supplementation[ J]. Lipids Health Dis, 2008, 7:27.
  • 9Bartus M, Lomnicka M, Lorkowska B, et al. Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat[ J ]. Pharmacol Rep, 2005, 57 ( supl ), 127 - 137.
  • 10Buchwalow IB, Podzuweit T, Bocker W, et al. Vascular smooth muscle and nitric oxide synthase[ J]. FASEB J, 2002, 16 (6) : 500 - 508.

二级参考文献55

  • 1王秀红,路方红.内皮素、一氧化氮与心血管疾病[J].中国慢性病预防与控制,2005,13(3):139-141. 被引量:32
  • 2王秋娟,潘志伟,岳攀,孔令义.淫羊藿总黄酮对动物实验性心肌缺血及血液流变学的影响[J].中草药,2007,38(7):1039-1042. 被引量:14
  • 3沈磊,张鸽,吴玉林.淫羊藿总黄酮对大鼠局灶性脑缺血的保护作用[J].中药新药与临床药理,2007,18(4):266-269. 被引量:9
  • 4John E. D, Julian P H, Ton J R. Endothelial Function and Dysfunction [J]. (Testing and Clinical Relevance) Circulation, 2007, 115 (3): 1285- 1295.
  • 5Vita JA, Keaney JF. Endothelial function: a barometer for cardiovascular risk [J]. Circulation, 2002, 106 (2): 640-642.
  • 6Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I. Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension [J]. J Hypertens, 2005, 23 (1): 7-17.
  • 7Tardif JC, Heinonen T, Orloff D, et al. Vascular biomarkers and surrogates in cardiovascular disease [J].Circulation, 2006, (113): 2936-2942.
  • 8Grafe M, Auch-Schwelk W, Hertel H, et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL [J]. Atherosclerosis, 1998, 137 (2): 87-95.
  • 9Watanabe T, Pakala R, Katagiri T, et al. Lysophosphatidyl- choline is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation [J]. J Cardiovasc Pharmacol, 2002, 39 (3): 449.
  • 10Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity [J]. N Engl J Med, 1989, 320 (14): 915- 924.

共引文献29

同被引文献212

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部